These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1327 related items for PubMed ID: 22736495

  • 1. Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.
    How J, Sykes J, Gupta V, Yee KW, Schimmer AD, Schuh AC, Minden MD, Kamel-Reid S, Brandwein JM.
    Cancer; 2012 Dec 15; 118(24):6110-7. PubMed ID: 22736495
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U.
    Eur J Haematol; 2008 Mar 15; 80(3):208-15. PubMed ID: 18081718
    [Abstract] [Full Text] [Related]

  • 3. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Oct 15; 44(10):2038-46. PubMed ID: 23701943
    [Abstract] [Full Text] [Related]

  • 4. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.
    Ann Hematol; 2012 Nov 15; 91(11):1703-12. PubMed ID: 22733614
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
    Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.
    Ann Hematol; 2012 Jan 15; 91(1):9-18. PubMed ID: 21744003
    [Abstract] [Full Text] [Related]

  • 6. Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.
    Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M.
    Eur J Haematol; 2007 Jul 15; 79(1):17-24. PubMed ID: 17598835
    [Abstract] [Full Text] [Related]

  • 7. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Haferlach T, Bacher U, Alpermann T, Haferlach C, Kern W, Schnittger S.
    Leuk Res; 2012 Jan 15; 36(1):51-8. PubMed ID: 21621842
    [Abstract] [Full Text] [Related]

  • 8. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.
    Zhong L, Jia YQ, Meng WT, Ni X.
    Arch Pathol Lab Med; 2012 Jan 15; 136(1):84-9. PubMed ID: 22208491
    [Abstract] [Full Text] [Related]

  • 9. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N, Tosic N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Colovic M, Pavlovic S.
    Ann Hematol; 2007 Oct 15; 86(10):741-7. PubMed ID: 17579862
    [Abstract] [Full Text] [Related]

  • 10. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
    Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrózek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA.
    Cancer Res; 2001 Oct 01; 61(19):7233-9. PubMed ID: 11585760
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM.
    Hematology; 2014 Jan 01; 19(1):22-30. PubMed ID: 23540998
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H.
    Leuk Res; 2011 Apr 01; 35(4):492-8. PubMed ID: 20684989
    [Abstract] [Full Text] [Related]

  • 13. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
    Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF.
    Cancer; 2004 Sep 01; 101(5):989-98. PubMed ID: 15329908
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
    Green CL, Koo KK, Hills RK, Burnett AK, Linch DC, Gale RE.
    J Clin Oncol; 2010 Jun 01; 28(16):2739-47. PubMed ID: 20439648
    [Abstract] [Full Text] [Related]

  • 15. CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk.
    Park SH, Chi HS, Cho YU, Jang S, Park CJ.
    Leuk Res; 2013 Nov 01; 37(11):1488-94. PubMed ID: 24054719
    [Abstract] [Full Text] [Related]

  • 16. The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia.
    Del Poeta G, Ammatuna E, Lavorgna S, Capelli G, Zaza S, Luciano F, Ottone T, Del Principe MI, Buccisano F, Maurillo L, Panetta P, de Fabritiis P, Stasi R, Venditti A, Amadori S, Lo Coco F.
    Br J Haematol; 2010 May 01; 149(3):383-7. PubMed ID: 20148885
    [Abstract] [Full Text] [Related]

  • 17. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
    Park BG, Chi HS, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Ann Hematol; 2013 Apr 01; 92(4):451-7. PubMed ID: 23238897
    [Abstract] [Full Text] [Related]

  • 18. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.
    Brunet S, Labopin M, Esteve J, Cornelissen J, Socié G, Iori AP, Verdonck LF, Volin L, Gratwohl A, Sierra J, Mohty M, Rocha V.
    J Clin Oncol; 2012 Mar 01; 30(7):735-41. PubMed ID: 22291086
    [Abstract] [Full Text] [Related]

  • 19. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
    Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H, German-Austrian Acute Myeloid Leukemia Study Group.
    N Engl J Med; 2008 May 01; 358(18):1909-18. PubMed ID: 18450602
    [Abstract] [Full Text] [Related]

  • 20. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.
    Guièze R, Cornillet-Lefebvre P, Lioure B, Blanchet O, Pigneux A, Recher C, Bonmati C, Fegueux N, Bulabois CE, Bouscary D, Vey N, Delain M, Turlure P, Himberlin C, Harousseau JL, Dreyfus F, Béné MC, Ifrah N, Chevallier P, GOELAMS.
    Am J Hematol; 2012 Dec 01; 87(12):1052-6. PubMed ID: 22911473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.